Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

March 31, 2014

Conditions
Uterine FibroidsUterine Myomas
Interventions
DEVICE

Halt Procedure

The Halt 2000 Electrosurgical Radiofrequency Ablation System is indicated for use in percutaneous, laparoscopic and intraoperative, coagulation and ablation of soft tissue.

Trial Locations (11)

10461

Montefiore Medical Center, The Bronx

15213

Magee-Women's Hospital, Pittsburgh

48034

Wayne State University, Detroit

63017

St. Luke's Hospital, Chesterfield

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez de la Universidad Autonoma de Nuevo Leon. Facultad de Medicina, Monterrey

85015

Women's Health Research, Phoenix

89509

Athena Gynecology Medical Group, Reno

90033

USC Medical Center, Los Angeles

91145

Pasadena Premier Women's Health, Pasadena

94583

Reproductive Science Center, San Ramon

01010

Hospital Universitario Esperanza, Guatemala City

Sponsors
All Listed Sponsors
lead

Acessa Health, Inc.

INDUSTRY